Publication | Closed Access

PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples

MedicineGynecologyAnti-cancer ActivityCancer BiologyOvarian ModelsClinical Plasma SamplesCancer TreatmentRadiation OncologyOncologyCell BiologyCancer GrowthOvarian Cancer